Fundz

PBS Biotech Appoints Martin Simonetti as Chief Executive Officer

PRIVATENov 03, 2025

Position

Chief Executive Officer

Company

PBS Biotech

Martin Simonetti
msimonetti@pbsbiotech.com
CamarilloManufacturingBiotechnologyAgriculture and FarmingSoftwareHealth CareScience And EngineeringEducation

Description

PBS Biotech has announced the appointment of Martin Simonetti as Chief Executive Officer effective October 27, 2025. He brings over 40 years of biotech industry experience and leadership.

Quick answer

PBS Biotech Appoints Martin Simonetti as Chief Executive Officer (November 3, 2025). PBS Biotech is based in Camarillo, California, United States.

Who is the new Chief Executive Officer at PBS Biotech?
PBS Biotech named Martin Simonetti Chief Executive Officer, announced November 3, 2025.
What did PBS Biotech announce on November 3, 2025?
PBS Biotech has announced the appointment of Martin Simonetti as Chief Executive Officer effective October 27, 2025. He brings over 40 years of biotech industry experience and leadership.
What does PBS Biotech do?
PBS Biotech is a leading manufacturer of single-use bioreactor systems and provider of process development services.
Where is PBS Biotech based?
PBS Biotech is based in Camarillo, California, United States.
Which similar companies made leadership changes around the same time?
The Hain Celestial Group (December 15, 2025), ImmuCell (November 4, 2025), Redwire Corporation (October 7, 2025) and Aurora Cannabis (December 8, 2025) also announced leadership changes within 45 days of PBS Biotech.

Source: Fundz verified event record.

Other recent leadership changes in Agriculture and Farming and Science And Engineering

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at PBS Biotech, and when

A new leader at PBS Biotech brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day PBS Biotech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PBS Biotech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PBS Biotech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PBS Biotech

Location

Camarillo, California, United States

About

PBS Biotech is a leading manufacturer of single-use bioreactor systems and provider of process development services. PBS' bioreactors utilize proprietary Vertical-Wheel® technology to create homogeneous and scalable mixing conditions for a variety of sensitive cell therapy products and cell culture applications. PBS Biotech's vision is to become the world's standard manufacturing platform for allogeneic cell-based therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PBS Biotech changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Brian
Senior decision-maker at this company
••••••••@••••••••

See Brian's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for PBS Biotech's next move

Learn about Strategic plan

PBS Biotech changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.